Logo image of NCV

VIRTUS CONVERTIBLE & INCOME (NCV) Stock Price, Quote, News and Overview

NYSE:NCV - New York Stock Exchange, Inc. - US92838X8056 - Currency: USD

13  +0.14 (+1.09%)

After market: 12.98 -0.02 (-0.15%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NCV. NCV was compared to 0 industry peers in the Unkown industry. NCV has a bad profitability rating. Also its financial health evaluation is rather negative. NCV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NCV was profitable.
In multiple years NCV reported negative net income over the last 5 years.
In the past 5 years NCV reported 4 times negative operating cash flow.
NCV Yearly Net Income VS EBIT VS OCF VS FCFNCV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

Industry RankSector Rank
ROA 1.22%
ROE 1.51%
ROIC 1.92%
ROA(3y)0.72%
ROA(5y)0.79%
ROE(3y)-0.8%
ROE(5y)-0.1%
ROIC(3y)2.3%
ROIC(5y)3.19%
NCV Yearly ROA, ROE, ROICNCV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

NCV's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of NCV has declined.
In the last couple of years the Gross Margin of NCV has declined.
Industry RankSector Rank
OM 54.44%
PM (TTM) 27.76%
GM 56.89%
OM growth 3Y-14.92%
OM growth 5Y-9.87%
PM growth 3Y-42.16%
PM growth 5Y-27.95%
GM growth 3Y-15.54%
GM growth 5Y-10.23%
NCV Yearly Profit, Operating, Gross MarginsNCV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for NCV remains at a similar level compared to 1 year ago.
The number of shares outstanding for NCV has been increased compared to 5 years ago.
Compared to 1 year ago, NCV has an improved debt to assets ratio.
NCV Yearly Shares OutstandingNCV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
NCV Yearly Total Debt VS Total AssetsNCV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

NCV has an Altman-Z score of 0.93. This is a bad value and indicates that NCV is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.22 indicates that NCV is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 0.93
ROIC/WACCN/A
WACCN/A
NCV Yearly LT Debt VS Equity VS FCFNCV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

NCV has a Current Ratio of 0.73. This is a bad value and indicates that NCV is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.73 indicates that NCV may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.73
NCV Yearly Current Assets VS Current LiabilitesNCV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

NCV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 103.29%, which is quite impressive.
NCV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -41.62% yearly.
The Revenue has decreased by -3.61% in the past year.
Measured over the past years, NCV shows a very negative growth in Revenue. The Revenue has been decreasing by -18.53% on average per year.
EPS 1Y (TTM)103.29%
EPS 3Y-55.75%
EPS 5Y-41.62%
EPS Q2Q%-156%
Revenue 1Y (TTM)-3.61%
Revenue growth 3Y-23.45%
Revenue growth 5Y-18.53%
Sales Q2Q%-2.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCV Yearly Revenue VS EstimatesNCV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 433.33 indicates a quite expensive valuation of NCV.
NCV is valuated expensively when we compare the Price/Earnings ratio to 28.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 433.33
Fwd PE N/A
NCV Price Earnings VS Forward Price EarningsNCV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NCV Per share dataNCV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

NCV has a Yearly Dividend Yield of 6.80%, which is a nice return.
NCV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.47.
Industry RankSector Rank
Dividend Yield 6.8%

5.2 History

NCV has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
NCV Yearly Dividends per shareNCV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NCV Yearly Income VS Free CF VS DividendNCV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

More info and screens

VIRTUS CONVERTIBLE & INCOME

NYSE:NCV (4/25/2025, 8:26:18 PM)

After market: 12.98 -0.02 (-0.15%)

13

+0.14 (+1.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners24.84%
Inst Owner Change-2.61%
Ins Owners0.01%
Ins Owner Change0%
Market Cap293.67M
Analysts0
Price TargetN/A
Short Float %0.14%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield 6.8%
Yearly Dividend0.47
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date06-12 2025-06-12 (0.136)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 433.33
Fwd PE N/A
P/S 11.8
P/FCF N/A
P/OCF N/A
P/B 0.64
P/tB 0.64
EV/EBITDA N/A
EPS(TTM)0.03
EY0.23%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.1
BVpS20.28
TBVpS20.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.22%
ROE 1.51%
ROCE 2.58%
ROIC 1.92%
ROICexc 2%
ROICexgc 2%
OM 54.44%
PM (TTM) 27.76%
GM 56.89%
FCFM N/A
ROA(3y)0.72%
ROA(5y)0.79%
ROE(3y)-0.8%
ROE(5y)-0.1%
ROIC(3y)2.3%
ROIC(5y)3.19%
ROICexc(3y)2.32%
ROICexc(5y)3.2%
ROICexgc(3y)2.42%
ROICexgc(5y)3.37%
ROCE(3y)3.33%
ROCE(5y)4.37%
ROICexcg growth 3Y-26.44%
ROICexcg growth 5Y-17.32%
ROICexc growth 3Y-23.63%
ROICexc growth 5Y-17.32%
OM growth 3Y-14.92%
OM growth 5Y-9.87%
PM growth 3Y-42.16%
PM growth 5Y-27.95%
GM growth 3Y-15.54%
GM growth 5Y-10.23%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.73
Altman-Z 0.93
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.29%
EPS 3Y-55.75%
EPS 5Y-41.62%
EPS Q2Q%-156%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.61%
Revenue growth 3Y-23.45%
Revenue growth 5Y-18.53%
Sales Q2Q%-2.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-45.19%
EBIT growth 3Y-34.87%
EBIT growth 5Y-26.58%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A